Continuation Guidance – Budget Year Five Attachment J– CHEMPACK Public Health Preparedness and Response for Bioterrorism June 14, 2004
Continuation Guidance – Budget Year Five
CHEMPACK Program Description
Participation in CHEMPACK is strictly voluntary for public health agencies. Keep in mind, however, there are other entities in the state that might choose to participate even if the public health department chooses not to (e.g., emergency management).
Jurisdictions receiving the CHEMPACK must ensure that the storage locations be of a suitable size, designed to provide adequate lighting, ventilation, temperature, sanitation, humidity, space, and security conditions for storage of pharmaceuticals.
Based on a pilot study conducted in New York City, South Dakota, and Washington State, the average cost for CHEMPACK container storage is expected to be approximately $2,000 to $2,500. It is imperative that Public Health work in collaboration with the appropriate Emergency Response Agencies to implement the CHEMPACK program.
Funding for the initial CHEMPACK installation and sustaining cost can be defrayed by a variety of funding sources including local, state, other federal such as HRSA or MMRS, and private funds.
Recipients of funding through the Cooperative Agreement for Public Health Preparedness and Response for Terrorism can also request redirection of current year funds or carry over un-obligated prior-year funds, to support the costs associated with receiving and managing CHEMPACK materiel. Redirection and carryover requests must contain a statement listing which program activities will not be completed if the request is approved. All requests must be forwarded to the CDC Procurement and Grants Office (PGO).
Questions related to cooperative agreement funds should be directed to the appropriate project officer in the OTPER Division of State and Local Preparedness.
Page 1 of 8
Strategic National Stockpile Program (SNS)
Office of Terrorism Prevention and Emergency Response (OTPER)
Centers for Disease Control and Prevention (CDC)
Terrorist attacks against United States citizens and US interests around the world culminated
in the mass destruction of the World Trade Center and damage to the Pentagon on September
11, 2001. Intelligence sources believe that terrorist groups will continue their destructive
activities and may use unconventional weapons in order to maximize casualties. To defend
against these threats, planners and responders must be able to quickly mobilize resources to
minimize and mitigate the effect of a nuclear, biological, chemical, or radiological terrorist
attack. While preventing such an event is the primary goal, it is probable that not all terrorist
efforts can be stopped. In the aftermath of a weapon of mass destruction (WMD) event, first
responders will focus on response activities designed to mitigate morbidity, mortality and
destruction of property.
One scenario involves terrorists using chemical weapons. Terrorist organizations may have
access to many different types of chemical agents to use in WMD attacks. The likely choice
may be nerve agents. Depending on the dose, nerve agents can cause immediate nervous
system failure and death. Nerve agent antidotes include:
? Atropine sulfate, which blocks the effects of excess acetylcholine at its site of action;
? Pralidoxime chloride (2PAM), which reactivates acetyl cholinesterase, and therefore
reduces the levels of acetylcholine; and
? Diazepam, which reduces the severity of acetylcholine-induced convulsions that can
contribute to death or long term neurological effects in survivors.
The SNS Program has numerous caches of medical equipment, pharmaceuticals and vaccines
in strategic locations throughout the United States, including the medicines described above.
Under its mandate, the SNS Program has a maximum 12-hour response time. However, this
response time is inadequate for a nerve agent event, where treatment must be accomplished
quickly in order to save as many lives as possible.
As a result, the Centers for Disease Control and Prevention has established a voluntary
participation project (CHEMPACK) for the “forward” placement of sustainable repositories
of nerve agent antidotes in numerous locations throughout the United States, so that they can
be immediately accessible for the treatment of affected persons. Under this project, the SNS
? maintain ownership of the CHEMPACK stockpile;
Page 2 of 8
? in conjunction with state and local officials, place the antidotes in numerous strategically
placed containers under controlled and monitored storage conditions for use in the event
of an emergency involving nerve agents .;
? implement strategies to maximize the shelf life of the antidotes to minimize re-
procurement costs and maintain quality, specifically through the Federal Drug
Administration’s (FDA) Shelf Life Extension Program (SLEP).
This approach allows the SNS Program to maintain accountability and the centralized control
of the caches to fulfill the criteria for the SLEP program while making the caches
immediately available to state / local authorities in case of an actual event involving nerve
agents. To meet the objectives of CHEMPACK deployment, states / cities (i.e., CDC 62 BT
Project recipients) and the SNS Program incur specific responsibilities as set forth below.
State and Local Responsibilities
The state / city will provide overall management of the state / city-wide CHEMPACK Project
and will oversee the receipt, storage, monitoring, maintenance and potential deployment of
The state / city will:
1. agree to authorize breaking the CHEMPACK container seal and making use of the
packaged products only when it is determined that an accidental or intentional nerve
agent release has threatened the public health security of the community. Providing
treatment to the American people after a nerve agent incident through CHEMPACK
Project assets is very expensive. The project will remain economically feasible only if its
materiel is used prudently and maintained under conditions that allow the SNS Program
to extend its shelf-life in cooperation with the FDA. Therefore, the undersigned agrees to
maintain unbroken the seal on all CHEMPACK containers and use project materiel only
when it determines that other means to save human life will not be sufficient. For
instance, if a farmer is overcome by exposure to insecticides and can be saved by using
local antidotes to treat the exposure or by a life-flight helicopter ride to a facility that has
the antidotes, the undersigned will elect that option in preference to breaking the seal of a
CHEMPACK container and using its materiel (an action that would prevent the SNS
Program from extending the shelf-life of unused material in the container).
2. designate a single and specific state / city wide point of contact (POC) for CHEMPACK.
3. determine the quantity and type of CHEMPACK containers (EMS / Hospital), required to
meet the needs of state and local first responders to respond to a nerve agent event within
stipulated budget constraints;
4. provide the address of each cache storage location and ensure coordinated access to SNS
Program personnel to cache locations as needed to monitor CHEMPACK materiel and;
Page 3 of 8
5. develop plans for CHEMPACK Project deployment, surveillance and maintenance
6. identify a pharmaceutical or medical professional with a DEA registration at each cache
storage location who will sign for and accept custody of the Scheduled IV narcotics and
other pharmaceuticals in the CHEMPACK containers. That person will be responsible for
the storage and safeguarding of the DEA compliant container in the facility and ensure
compliance with applicable local, State and Federal Regulatory guidelines. The SNS
Program retains ownership of the CHEMPACK materiel and will ensure the integrity of
the pharmaceuticals for the Shelf Life Extension Program.
The state / city will ensure the provision of the following facilities
or conditions for each CHEMPACK cache storage location.
A. Container Storage
1) The state / city shall require that cache storage locations be of a suitable size,
designed to provide adequate lighting, ventilation, temperature, sanitation, humidity,
space, and security conditions for storage of pharmaceuticals and conform to
standards in reference B. This will generally include:
a) provide a locked room or cage. The CHEMPACK container is constructed of
Lexan? mesh and is approved by the Drug Enforcement Agency (DEA) for
storage of Class IV controlled drugs. For this reason, there is no requirement for
floor to ceiling construction. The purpose of the enclosed room or cage is to
control access and ensure compliance with applicable Federal, State and Local
b) install an intrusion detection device, directed towards the CHEMPACK containers,
to alert cache location security or pharmacy personnel of possible intrusion into
the storage area. The sensor must be physically monitored on a 24-hour basis by
security or pharmacy personnel. Cache location security managers will test the
interior devices according to manufacturer specifications to ensure proper
c) ensure a minimum clearance of 72” aisles and 45” doorways to maneuver
containers in and out of the storage location.
d) provide a minimum of 50 sq. ft. of floor space per container at each cache
e) ensure accessibility to CHEMPACK containers. CHEMPACK container
dimensions are 64” long X 44” wide X 60.5” high and weigh 500 - 700 pounds.
f) ensure CHEMPACK containers are stored in a climate-controlled environment
with a thermostat that automatically maintains room temperature between 59 to
86 degrees Fahrenheit (15 degrees and 30 degrees Celsius). Humidity must be
maintained below 60% to prevent visible mold growth.
Page 4 of 8
g) provide one dedicated data quality analog phone line per Sensaphone? (this line
may not be a shared line).
h) ensure one dedicated standard 120VAC, 60HZ, 10W, UL-listed power outlet and
a back-up power source per Sensaphone? (uninterruptible power supply (UPS) or
existing facility emergency generator is adequate).
i) ensure each container is locked with a padlock and access to the key is limited;
key control shall be the responsibility of the cache location pharmacy director.
j) provide a fire detection and alarm device and, adequate fire suppression in
accordance with applicable Federal, State and Local pharmacy regulations and
k) provide standard lighting to ensure CHEMPACK personnel can clearly see lot
numbers and product expiration dates as required by applicable Federal, State and
Local pharmacy regulations.
l) ensure proper disposal of expired CHEMPACK medical materiel not in the SLEP
program; upon material replacement by SNS personnel.
2) The state / city shall identify a pharmacy or medical professional with a DEA
registration at each cache location to sign for and accept custody of the Scheduled IV
narcotics and other pharmaceuticals in a CHEMPACK container.
B. Quality Control
The state / city shall require each cache storage location to designate:
1) personnel to conduct joint inventories and monthly security checks to visually inspect
SNS Program seals on the CHEMPACK containers (in accordance with applicable
Federal and State regulations the person signing for custody must be a Registered
Pharmacist or his / her designee); and
2) personnel to conduct quality control checks at each cache location to ensure that the
climate is within acceptable environmental limits and to send a quality control (QC)
report to SNS Program each month or as requested by SNS Program to document
storage conditions at each cache location.
C. Correct Out-Of-Compliance Conditions
The state / city shall ensure cache storage locations apply resources and assets to correct
non-complying environmental and security conditions in a timely manner (usually within
two hours). When conditions cannot be corrected within 12 hours, the State
CHEMPACK point of contact will coordinate with the SNS Program point of contact for
movement of the CHEMPACK container(s) to an acceptable location to protect the
quality or security of the materiel.
Page 5 of 8
SNS Program Responsibilities
The SNS Program will:
1. Establish a maximum number of caches the State may have in order to maintain
acceptable cost savings under the Shelf Life Extension Program (SLEP). Refer to
2. Develop standardized container packages with a treatment formulary to treat patients for
nerve agent exposure, using exposure rates of 30% mild, 40% moderate, and 30% severe.
3. Deliver the CHEMPACK materiel to state designated cache storage locations; once the
state has identified the required number and type of CHEMPACK containers EMS or
Hospital. The materiel will be maintained in CHEMPACK containers equipped with a
Sensaphone?, back-up monitoring system, instructions on how to read the back-up
climate control monitoring system, and serial numbered container seals.
4. Provide DEA approved storage containers to hold CHEMPACK materiel.
5. Provide an SNS Program fielding team to install the CHEMPACK containers at state
designated cache locations, conduct a joint inventory with designated cache location
personnel, and validate the operational status of CHEMPACK environmental and
security monitoring equipment.
6. Ensure the schedule IV drugs are secured in a locked DEA approved CHEMPACK
container, monitoring devices are operational, and the designated pharmacy or medical
professional with a DEA registration has inventoried and assumed custody of the materiel.
7. Retain ownership of all CHEMPACK materiel to ensure the integrity of the
pharmaceuticals for the SLEP, until or unless the CHEMPACK is used.
8. Provide resources and assets required to sample, restock, re-label, and dispose of
CHEMPACK materiels subject to the SLEP.
9. Provide resources and assets required to perform surveillance and QA/QC of
CHEMPACK assets over the life of the Project.
10. Conduct periodic quality assurance and quality control inspections to verify inventory,
storage conditions and security of CHEMPACK materiel.
1. The SNS Program will not automatically replace any CHEMPACK materiel used in
response to an actual nerve agent event. Replacement of materiel lost due to natural
Page 6 of 8
disasters, accidents, or negligence will be negotiated between the State and the SNS
2. Once the State has broken the SNS Program seal on a CHEMPACK container the
medical materiel in that container is no longer eligible for the SLEP program.
3. CHEMPACK containers may be moved preemptively to facilitate response during state
designated special events, with the following stipulations:
? The State / city CHEMPACK POC or backup must notify the SNS Program at least
48 hours prior to the preemptive movement of CHEMPACK containers.
? All movements of CHEMPACK materiel not specifically directed by the SNS
Program shall be funded by the State.
4. The state / city must notify the SNS Program CHEMPACK Logistics Team within two
hours if a CHEMPACK cache storage location loses climate control.
1. Funding for the initial CHEMPACK installation and sustaining cost can be defrayed by a
variety of funding sources including local, state, and other federal such as DHS, DOJ,
MMRS, and private funds.
2. State Public Health Departments receiving funding through the Centers for Disease
Control and Prevention (CDC) Cooperative Agreement for Public Health Preparedness
and Response for Terrorism (BTCA) are encouraged to request redirection of current year
funds or carry over unobligated prior-year funds, to support the costs associated with
receiving and managing CHEMPACK materiel. Redirection and carryover request
sshould be sent through normal channels to the CDC Procurement and Grants Office
(PGO). Questions related to CDC BT cooperative agreement funds should be directed to
the appropriate project officer in the Office of Terrorism Preparedness and Emergency
Response (OTPER) State and Local Preparedness Program (SLPP).
3. The HRSA National Bioterrorism Hospital Preparedness Program (NBHPP) has joined
with the SNS Program CHEMPACK Project to support cache build-out. NBHPP funds
earmarked for Medications and Medical supplies may be used to offset reasonable costs
associated with the retrofit of CHEMPACK cache storage facilities to meet FDA / SLEP
requirements. Questions related the use of these funds should be directed to the HRSA
Coordinator in your state or directly to HRSA NBHPP.
4. The states / cities will not be responsible for any costs related to the CHEMPACK
containers/chemical antidotes, or transportation cost for initial instillation. The SNS
Program will allocate CHEMPACK containers to states and cities, based upon their
population (2000 US Census).
Page 7 of 8
Points of Contact
For SNS Program: David E. Adcock, CHEMPACK National Coordinator, CHEMPACK
program; voice (404) 687-6750; Fax: (404) 687-6760, email: DEA1@CDC.gov or John
Michaels, CHEMPACK Program Manager, voice: (404) 687-6507; Fax: (404) 687-6758;
Page 8 of 8